However, FOP patient-derived endothelial cells from induced pluripotent human stem cells did not show SMAD1/5/8 activation after activin A treatment, and no significant differences have been found in the serum levels of activin A, BMP4, or BMP6 in FOP patients [56,58]. This evidence concerns the gene SMAD1 and fibrodysplasia ossificans progressiva.